4.7 Article

Analysis of Acute and Chronic Methamphetamine Treatment in Mice on Gdnf System Expression Reveals a Potential Mechanism of Schizophrenia Susceptibility

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Increased Physiological GDNF Levels Have No Effect on Dopamine Neuron Protection and Restoration in a Proteasome Inhibition Mouse Model of Parkinson?s Disease

Soophie Olfat et al.

Summary: Parkinson's disease is a progressive neurodegenerative disease with a wide range of motor and nonmotor symptoms. Glial cell line-derived neurotrophic factor (GDNF) has been tested in clinical trials for PD treatment, but the results have been variable. This study aimed to investigate the therapeutic potential of endogenous GDNF in a mouse model of PD.

ENEURO (2023)

Review Pharmacology & Pharmacy

Pralsetinib: Treatment of metastatic RET fusion-positive non-small cell lung cancer

Ly Nguyen et al.

Summary: This article reviews the pharmacology, efficacy, safety, dosing and administration, and place in therapy of pralsetinib for the treatment of metastatic RET fusion-positive non-small-cell lung cancer (NSCLC). Pralsetinib has shown high response rates in patients previously treated with platinum chemotherapy and treatment naive patients. Clinicians should monitor and manage potential side effects when using pralsetinib.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2022)

Article Cell & Tissue Engineering

A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells

Niamh Moriarty et al.

Summary: This study demonstrates the remarkable capacity for achieving precise reconstruction of brain-wide mDA target innervation in the adult brain through viral delivery of GDNF to the striatum, in conjunction with homotopic transplantation of human pluripotent stem-cell-derived mDA neurons.

CELL STEM CELL (2022)

Review Pharmacology & Pharmacy

Pralsetinib: A Review in Advanced RET Fusion-Positive NSCLC

Yahiya Y. Syed

Summary: Pralsetinib has shown promising efficacy as a targeted treatment option for patients with advanced RET fusion-positive NSCLC, both in terms of overall tumor activity and its effect on intracranial metastases from NSCLC.
Article Biochemistry & Molecular Biology

Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia

Kart Matlik et al.

Summary: This study found that increased striatal dopamine signaling in a subgroup of schizophrenia patients may be related to the increase of GDNF. A possible mediator of GDNF-driven dopaminergic abnormalities is A(2A)R. By inhibiting A(2A)R with a drug, striatal and cortical dopamine levels can be partially normalized. These results provide potential therapeutic targets for the treatment of schizophrenia.

MOLECULAR PSYCHIATRY (2022)

Article Biochemistry & Molecular Biology

Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome

David W. Greening et al.

Summary: Studies have shown that chronic Meth abuse can lead to psychotic episodes resembling schizophrenia, with Brain-derived neurotrophic factor (BDNF) playing a crucial role in this process. Research on transgenic mice revealed that BDNF genetic variation significantly influences the long-term brain changes induced by Meth, indicating that drug-induced psychosis may be modulated at the molecular level by a single genetic locus.

MOLECULAR PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

The Gene Ontology resource: enriching a GOld mine

Seth Carbon et al.

Summary: The Gene Ontology Consortium has made advancements in the last two years, such as improving the GO-CAM annotation framework, increasing the number of annotations and annotated gene products, and reviewing older annotations for consistency.

NUCLEIC ACIDS RESEARCH (2021)

Review Psychiatry

Maternal Immune Activation and Schizophrenia-Evidence for an Immune Priming Disorder

Zahra Choudhury et al.

Summary: Schizophrenia is a complex neurodevelopmental disorder affecting a large number of people worldwide. The etiology involves genetic and environmental factors, with maternal immune activation during pregnancy implicated in increasing risk. Animal models and genome wide association studies have provided insights into the mechanisms, but research is still ongoing.

FRONTIERS IN PSYCHIATRY (2021)

Article Clinical Neurology

Changes in subunit composition of NMDA receptors in animal models of schizophrenia by repeated administration of methamphetamine

Matsuhiko Oka et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)

Article Biochemistry & Molecular Biology

Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study

Sameer Jauhar et al.

MOLECULAR PSYCHIATRY (2019)

Review Biochemistry & Molecular Biology

Current Concepts and Treatments of Schizophrenia

Piotr Stepnicki et al.

MOLECULES (2018)

Review Neurosciences

Biology of GDNF and its receptors - Relevance for disorders of the central nervous system

Carlos F. Ibanez et al.

NEUROBIOLOGY OF DISEASE (2017)

Review Chemistry, Medicinal

Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors

Eun-Joo Shin et al.

ARCHIVES OF PHARMACAL RESEARCH (2017)

Article Clinical Neurology

BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine

Elizabeth E. Manning et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)

Article Medicine, Research & Experimental

Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration

Durga Praveen Meka et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Letter Neurosciences

GDNF is not required for catecholaminergic neuron survival in vivo

Jaakko Kopra et al.

NATURE NEUROSCIENCE (2015)

Article Biochemistry & Molecular Biology

miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF

Kart Varendi et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2014)

Article Clinical Neurology

Methamphetamine Psychosis: Epidemiology and Management

Suzette Glasner-Edwards et al.

CNS DRUGS (2014)

Article Genetics & Heredity

Treatment-resistant schizophrenia and DAT and SERT polymorphisms

Petar Bilic et al.

Article Neurosciences

BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation

Elizabeth E. Manning et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2013)

Review Neurosciences

Perinatal complications and schizophrenia: involvement of the immune system

Trisha A. Jenkins

FRONTIERS IN NEUROSCIENCE (2013)

Review Psychiatry

The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment

Oliver D. Howes et al.

ARCHIVES OF GENERAL PSYCHIATRY (2012)

Review Neurosciences

Methamphetamine-Associated Psychosis

Kathleen M. Grant et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)

Review Biochemistry & Molecular Biology

Tyrosine hydroxylase and regulation of dopamine synthesis

S. Colette Daubner et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)

Review Pharmacology & Pharmacy

Animal models of schizophrenia

C. A. Jones et al.

BRITISH JOURNAL OF PHARMACOLOGY (2011)

Article Urology & Nephrology

The GDNF Target Vsnl1 Marks the Ureteric Tip

Roxana Ola et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)

Article Genetics & Heredity

Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis

Benson C. Lu et al.

NATURE GENETICS (2009)

Review Psychiatry

The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway

Oliver D. Howes et al.

SCHIZOPHRENIA BULLETIN (2009)

Article Multidisciplinary Sciences

Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics

Bernard Masri et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Substance Abuse

The prevalence of psychotic symptoms among methamphetamine users

Rebecca McKetin et al.

ADDICTION (2006)

Letter Biochemistry & Molecular Biology

Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain

S Love et al.

NATURE MEDICINE (2005)

Article Psychiatry

Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia

J Hirvonen et al.

ARCHIVES OF GENERAL PSYCHIATRY (2005)

Review Neurosciences

The GDNF family: Signalling, biological functions and therapeutic value

MS Airaksinen et al.

NATURE REVIEWS NEUROSCIENCE (2002)